XML 64 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
12 Months Ended
Jul. 31, 2014
Income Tax Disclosure [Abstract]  
Income Taxes
Income Taxes

The provision for income taxes from continuing operations consisted of the following for the periods indicated:

 
Twelve Months Ended July 31,
(In millions)
2014
 
2013
 
2012
Current:
 
 
 
 
 
Federal
$
324

 
$
307

 
$
363

State
20

 
28

 
28

Foreign
10

 
5

 
2

 Total current
354

 
340

 
393

Deferred:
 
 
 
 
 
Federal
91

 
34

 
(23
)
State
6

 
2

 
(4
)
Foreign
2

 
11

 
8

Total deferred
99

 
47

 
(19
)
Total provision for income taxes from continuing operations
$
453

 
$
387

 
$
374




Excess tax benefits associated with share-based compensation deductions are credited to stockholders’ equity. The reductions of income taxes payable resulting from share-based compensation deductions that were credited to stockholders’ equity were approximately $82 million for the twelve months ended July 31, 2014, $69 million for the twelve months ended July 31, 2013, and $71 million for the twelve months ended July 31, 2012.

The sources of income from continuing operations before the provision for income taxes consisted of the following for the periods indicated:

 
Twelve Months Ended July 31,
(In millions)
2014
 
2013
 
2012
United States
$
1,290

 
$
1,165

 
$
1,096

Foreign
24

 
45

 
42

Total
$
1,314

 
$
1,210

 
$
1,138




Differences between income taxes calculated using the federal statutory income tax rate of 35% and the provision for income taxes from continuing operations were as follows for the periods indicated:

 
Twelve Months Ended July 31,
(In millions)
2014
 
2013
 
2012
Income from continuing operations before income taxes
$
1,314

 
$
1,210

 
$
1,138

 
 
 
 
 
 
Statutory federal income tax
$
460

 
$
424

 
$
398

State income tax, net of federal benefit
17

 
17

 
16

Federal research and experimentation credits
(8
)
 
(24
)
 
(8
)
Domestic production activities deduction
(25
)
 
(29
)
 
(27
)
Share-based compensation
9

 
7

 
8

Effects of non-U.S. operations
1

 
(2
)
 
(5
)
Other, net
(1
)
 
(6
)
 
(8
)
Total provision for income taxes from continuing operations
$
453

 
$
387

 
$
374



In January 2013 the American Taxpayer Relief Act of 2012 was signed into law. The Act includes a reinstatement of the federal research and experimentation credit through December 31, 2013 that was retroactive to January 1, 2012. We recorded a discrete tax benefit of approximately $8 million for the retroactive effect during the twelve months ended July 31, 2013. As of July 31, 2014, the federal research and experimentation credit has not been extended beyond December 31, 2013.

Significant deferred tax assets and liabilities were as follows at the dates indicated:
 
July 31,
(In millions)
2014
 
2013
Deferred tax assets:
 
 
 
Accruals and reserves not currently deductible
$
60

 
$
51

Deferred rent
11

 
11

Accrued and deferred compensation
50

 
50

Loss and tax credit carryforwards
47

 
36

Property and equipment

 
12

Share-based compensation
50

 
97

Net basis difference in investments held for sale

 
41

Other, net
2

 

Total deferred tax assets
220

 
298

Deferred tax liabilities:
 
 
 
Intangible assets
120

 
93

Property and equipment
4

 

Other, net

 
10

Total deferred tax liabilities
124

 
103

Total net deferred tax assets
96

 
195

Valuation allowance
(24
)
 
(25
)
Total net deferred tax assets, net of valuation allowance
$
72

 
$
170



The components of total net deferred tax assets, net of valuation allowances, as shown on our balance sheets were as follows at the dates indicated:
 
July 31,
(In millions)
2014
 
2013
Current deferred income taxes
$
133

 
$
166

Long-term deferred income taxes included in other assets

 
10

Long-term deferred income taxes included in other long-term obligations
(61
)
 
(6
)
Total net deferred tax assets, net of valuation allowance
$
72

 
$
170



We provide U.S. federal income taxes on the earnings of foreign subsidiaries unless the subsidiaries' earnings are intended to be indefinitely reinvested in our international operations. To the extent that foreign earnings previously treated as indefinitely reinvested are repatriated, the related U.S. tax liability may, subject to certain limitations, be reduced by any foreign income taxes paid on these earnings. At July 31, 2014, the cumulative amount of earnings upon which U.S. income taxes had not been provided was approximately $48 million. The unrecognized deferred tax liability for these earnings was approximately $7 million.
We have provided a valuation allowance related to the benefits of federal and state net basis difference in investments held for sale, state capital and operating loss carryforwards, foreign operating loss carryforwards, and state tax credit carryforwards that we believe are unlikely to be realized. Changes in the valuation allowance during the twelve months ended July 31, 2014 were primarily related to the reduction of the valuation allowance on the loss associated with the sale of our Intuit Health investment, partially offset by the increase of the valuation allowance related to state tax credit and state and foreign operating loss carryforwards. Changes in the valuation allowance during the twelve months ended July 31, 2013 were primarily related to the federal and state net basis difference in investments held for sale. The deferred tax assets for the net basis difference in the Intuit Financial Services and Intuit Health investments held for sale were $9 million and $32 million, on which we recorded valuation allowances of $1 million and $14 million. We recorded the related tax benefits of $8 million and $18 million to net gain on disposal of discontinued operations. See Note 7, “Discontinued Operations,” for more information.

At July 13, 2013, the deferred tax asset for the capital loss on the sale of Intuit Websites was $16 million, on which there was a valuation allowance of $2 million for state capital loss carryfowards. The deferred tax asset for the net basis difference in the Intuit Websites investment held for sale at the end of fiscal 2012 was $38 million, on which we recorded a valuation allowance of $2 million. We recorded the related tax benefit to net income from discontinued operations in fiscal 2012.

At July 31, 2014, we had total federal net operating loss carryforwards of approximately $61 million that will start to expire in fiscal 2021. Utilization of the net operating losses is subject to annual limitation. The annual limitation may result in the expiration of net operating losses before utilization.

At July 31, 2014, we had total state net operating loss carryforwards of approximately $183 million for which we have recorded a deferred tax asset of $11 million and a valuation allowance of $9 million. The state net operating losses will start to expire in fiscal 2015. Utilization of the net operating losses is subject to annual limitation. The annual limitation may result in the expiration of net operating losses before utilization.

At July 31, 2014, we had Singapore operating loss carryforwards of approximately $18 million which have an indefinite carryforward period. We recorded a full valuation allowance on the related deferred tax asset.

At July 31, 2014, we had California research and experimentation credit carryforwards of approximately $27 million. If realized, $7 million of the carryfoward will be recognized as additional paid in capital. We recorded a full valuation on the related deferred tax asset.

Unrecognized Tax Benefits

The aggregate changes in the balance of our gross unrecognized tax benefits were as follows for the periods indicated:

 
Twelve Months Ended July 31,
(In millions)
2014
 
2013
 
2012
Gross unrecognized tax benefits, beginning balance
$
39

 
$
38

 
$
41

Increases related to tax positions from prior fiscal years, including acquisitions
4

 
5

 
3

Decreases related to tax positions from prior fiscal years
(8
)
 
(12
)
 
(9
)
Increases related to tax positions taken during current fiscal year
5

 
9

 
3

Settlements with tax authorities

 
(1
)
 

Gross unrecognized tax benefits, ending balance
$
40

 
$
39

 
$
38




The total amount of our unrecognized tax benefits at July 31, 2014 was $40 million. Net of related deferred tax assets, unrecognized tax benefits were $26 million at that date. If we were to recognize these net benefits, our income tax expense would reflect a favorable net impact of $26 million. We do not believe that it is reasonably possible that there will be a significant increase or decrease in unrecognized tax benefits over the next 12 months.

We file U.S. federal, U.S. state, and foreign tax returns. Our major tax jurisdictions are U.S. federal and the State of California. For U.S. federal tax returns we are no longer subject to tax examinations for years prior to fiscal 2010. For California tax returns we are no longer subject to tax examinations for years prior to fiscal 2007. We are currently under examination by the Internal Revenue Service for fiscal 2010 through 2012 and by the California Franchise Tax Board for fiscal 2007 and 2008.

We recognize interest and penalties related to unrecognized tax benefits within the provision for income taxes. Amounts accrued at July 31, 2014 and July 31, 2013 for the payment of interest and penalties were not significant. The amounts of interest and penalties that we recognized during the twelve months ended July 31, 2014, 2013 and 2012 were also not significant.